About the Fraction Absorbed Calculator

This guide provides a comprehensive overview of the principles behind our Fraction Absorbed calculator. Understanding these concepts is essential for accurately interpreting the tool’s results in pharmacokinetic studies, drug development, and clinical pharmacology education.

What This Calculator Does

The primary function of this tool is to determine the Fraction Absorbed (Fa) of a drug. Fa represents the proportion of an orally administered dose that successfully passes from the gastrointestinal (GI) tract into the portal circulation (the blood vessel system that leads to the liver).

It achieves this by comparing dose-normalized pharmacokinetic data from an oral administration study against data from an intravenous (IV) administration study. The IV data serves as a baseline, representing 100% of the drug reaching the systemic circulation without any absorption barriers.

In its advanced mode, the calculator can also estimate the overall Systemic Bioavailability (F), which is the fraction of the administered dose that reaches the systemic circulation unchanged. This calculation accounts for drug loss not only during absorption but also due to metabolism in the gut wall (Fg) and the liver (Fh) before it can circulate throughout the body.

When to Use It

This calculator is a valuable educational and research tool for:

• Pharmacology Students: To understand the fundamental concepts of absorption, bioavailability, and first-pass metabolism.
• Drug Development Scientists: In early-phase research to assess the absorption characteristics of new chemical entities and compare different drug formulations.
• Clinical Researchers: To analyze data from bioequivalence studies or to understand how factors like food or other drugs might affect absorption.
• Clinicians: As an educational resource to better grasp why oral and IV doses of the same drug can differ significantly.

Inputs Explained

Oral Administration Data

• AUC (oral): The Area Under the plasma concentration-time Curve after taking the drug orally. It represents the total systemic exposure to the drug over time from an oral dose.
• Dose (oral): The amount of the drug administered in the oral formulation (e.g., 100 mg).

Intravenous (IV) Administration Data

• AUC (IV): The AUC measured after administering the drug directly into the bloodstream. This value, when dose-normalized, acts as the 100% bioavailability reference standard.
• Dose (IV): The amount of the drug administered intravenously (e.g., 10 mg).

Advanced Inputs (Optional)

• Fg (Fraction escaping gut metabolism): A value between 0 and 1 representing the proportion of the absorbed drug that survives metabolism by enzymes in the cells of the intestinal wall. An Fg of 0.9 means 90% escapes gut metabolism.
• Fh (Fraction escaping hepatic metabolism): A value between 0 and 1 representing the proportion of the drug reaching the liver that survives “first-pass” metabolism before entering the main circulatory system. An Fh of 0.4 means only 40% makes it past the liver initially.

Results Explained

The calculator provides two key outputs:

• Fraction Absorbed (Fa): A value between 0 and 1 (or 0% to 100%). It indicates how efficiently the drug is absorbed from the GI tract.
  • High Absorption (Fa ≥ 0.8): Most of the drug is absorbed.
  • Moderate Absorption (0.5 ≤ Fa < 0.8): A significant portion is absorbed, but there may be room for improvement.
  • Low Absorption (Fa < 0.5): Poor absorption is a major limiting factor for the drug’s oral efficacy.
• Systemic Bioavailability (F): Calculated only in advanced mode, this value represents the net result of all absorption and first-pass metabolism processes (F = Fa × Fg × Fh). It dictates the actual amount of active drug available to the body from an oral dose.

Formula / Method

The calculator uses standard pharmacokinetic formulas to derive its results. The core calculation for the Fraction Absorbed is based on the principle of dose normalization.

Fraction Absorbed (Fa) Formula

Fa = (AUC_oral / Dose_oral) / (AUC_iv / Dose_iv)

This formula compares the dose-adjusted exposure from the oral route to the dose-adjusted exposure from the IV route. The tool automatically handles unit conversions to ensure consistency.

Systemic Bioavailability (F) Formula

F = Fa * Fg * Fh

This formula extends the calculation to account for presystemic metabolism in the gut and liver, providing the true fraction of the drug that reaches the systemic circulation.

Step-by-Step Example

Let’s calculate the Fraction Absorbed for a hypothetical drug, “Exemplar”.

1. Gather Oral Data: After a 100 mg oral dose, the measured AUC was 2750 ng*h/mL.
2. Gather IV Data: After a 10 mg IV dose, the measured AUC was 290 ng*h/mL.
3. Normalize Oral Data:
   Normalized AUC_oral = AUC_oral / Dose_oral
= 2750 / 100 = 27.5 (ng*h/mL) / mg
4. Normalize IV Data:
   Normalized AUC_iv = AUC_iv / Dose_iv
= 290 / 10 = 29.0 (ng*h/mL) / mg
5. Calculate Fa:
   Fa = Normalized AUC_oral / Normalized AUC_iv
= 27.5 / 29.0 ≈ 0.948

The result, Fa ≈ 0.948, means that approximately 94.8% of the oral dose was absorbed from the GI tract. This indicates high absorption.

Tips + Common Errors

• Ensure Data Consistency: The oral and IV data should ideally come from the same study or from studies with very similar patient populations to be comparable.
• Double-Check Units: While the tool has built-in converters, always be mindful of the units you are entering. An error in magnitude (e.g., mg vs. µg) will drastically skew results.
• Fa vs. F: Do not confuse Fraction Absorbed (Fa) with overall Bioavailability (F). A drug can be well-absorbed but still have low bioavailability due to high first-pass metabolism.
• Fa > 100% Error: A calculated Fa greater than 1 (or 100%) is physiologically impossible. This result points to an error in the input data, issues with the laboratory assay, or complex non-linear pharmacokinetics where exposure does not increase proportionally with the dose.

Frequently Asked Questions

References

1. Gertz, M., Harrison, A., Houston, J. B., & Galetin, A. (2010). Prediction of human oral absorption and assessment of the impact of gut wall metabolism. Drug Metabolism and Disposition, 38(7), 1133–1140. https://pubmed.ncbi.nlm.nih.gov/20371698/
2. U.S. Food and Drug Administration. (2003). Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products — General Considerations. https://www.fda.gov/media/70951/download
3. Talevi, A., & Quiroga, P. L. (Eds.). (2018). ADME Processes in Pharmaceutical Sciences. Springer. Chapter: Oral Absorption.
4. Shargel, L., Yu, A. B. C., & Wu-Pong, S. (2012). Applied Biopharmaceutics & Pharmacokinetics (6th ed.). McGraw-Hill Education. Chapter 15: Bioavailability and Bioequivalence.

Disclaimer